연구성과로 돌아가기

2020 연구성과별 연구자 정보 (1681 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Kim, Cheol Hyeon Kim, CH 8 Korea Canc Ctr Hosp, Dept Internal Med, Seoul, South Korea swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Jang, Seung Hun Jang, SH 9 Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Kim, Young-Chul Kim, YC 10 Chonnam Natl Univ, Hwasun Hosp, Med Sch, Lung Canc Clin, Jeonnam, South Korea swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Yoon, Hyoung-Kyu Yoon, HK 11 Catholic Univ Korea, Yeouido St Marys Hosp, Dept Internal Med, Seoul, South Korea swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Han, Ji-Youn Han, JY 12 Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea HGU-6164-2022 Zhang, Jialiang swkim@amc.seoul.kr;
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Kim, Sang-We Kim, SW 13 교신저자 Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea AAN-9079-2021 Kim, Tae-Hee swkim@amc.seoul.kr;
Recent Advancements in Emerging Neuromorphic Device Technologies Woo, Jiyong Woo, J 1 교신저자 Elect & Telecommun Res Inst, ICT Creat Res Lab, Daejeon 34129, South Korea jiyong.woo@etri.re.kr;
Recent Advancements in Emerging Neuromorphic Device Technologies Woo, Jiyong Woo, J 1 교신저자 Kyungpook Natl Univ, Sch Elect Engn, 80 Daehakro, Daegu 41566, South Korea jiyong.woo@etri.re.kr;
Recent Advancements in Emerging Neuromorphic Device Technologies Kim, Jeong Hun Kim, JH 2 Elect & Telecommun Res Inst, ICT Creat Res Lab, Daejeon 34129, South Korea jiyong.woo@etri.re.kr;
Recent Advancements in Emerging Neuromorphic Device Technologies Im, Jong-Pil Im, JP 3 Elect & Telecommun Res Inst, ICT Creat Res Lab, Daejeon 34129, South Korea jiyong.woo@etri.re.kr;
Recent Advancements in Emerging Neuromorphic Device Technologies Moon, Seung Eon Moon, SE 4 Elect & Telecommun Res Inst, ICT Creat Res Lab, Daejeon 34129, South Korea jiyong.woo@etri.re.kr;
Recent advances in the formulation of sphingolipid anticancer therapeutics Choi, Min-Koo Choi, MK 1 Dankook Univ, Coll Pharm, Cheonan 31116, South Korea songimsook1@gmail.com;
Recent advances in the formulation of sphingolipid anticancer therapeutics Song, Im-Sook Song, IS 2 교신저자 Kyungpook Natl Univ, Coll Pharm, Daegu 41566, South Korea songimsook1@gmail.com;
Recent advances in the formulation of sphingolipid anticancer therapeutics Song, Im-Sook Song, IS 2 교신저자 Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Daegu 41566, South Korea songimsook1@gmail.com;
Recent Advances of Fluid Manipulation Technologies in Microfluidic Paper-Based Analytical Devices (μPADs) toward Multi-Step Assays Kim, Taehoon H. Kim, TH 1 CytoDx, Seongnam Si 13486, South Korea thkim@cytodx.co.kr;hahnv79@gmail.com;kms@dgist.ac.kr;
페이지 이동: